Registration

ARNOLD & PORTER KAYE SCHOLER LLP for ESTEVE PHARMACEUTICALS, LLC

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to reimbursement and coverage for certain drugs.

LobbyistCovered position, as disclosed
BOBBY MCMILLIN New General Counsel, Senate Health, Education, Labor, & Pensions (HELP) Committee (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)

Medicare/Medicaid MMM

Issues related to reimbursement and coverage for certain drugs.

LobbyistCovered position, as disclosed
BOBBY MCMILLIN New General Counsel, Senate Health, Education, Labor, & Pensions (HELP) Committee (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GRUPO ESTEVE LIFESCIENCES, S.L. (MAJORITY OWNER OF ESTEVE HEALTHCARE, S.L.) Spain Spain 74.0% —
LUBEA CATAMAN GMBH & CO.KG (MINORITY OWNER OF ESTEVE HEALTHCARE, S.L.) Germany Germany 26.0% —
ESTEVE HEALTHCARE, S.L. Spain Spain 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.